Rocaglamide Selectively Eradicates Human Leukemia Stem Cells and Synergizes with Multiple Agents to Target AML Cells

被引：0
|
作者：
Callahan, Kevin P. [1 ]
Corbett, Cheryl [1 ]
Jacob, Steven
Minhajuddin, Mohammad [1 ]
Lagadinou, Eleni D. [1 ]
Rossi, Randall M. [1 ]
Gross, Valerie [1 ]
Balys, Marlene [1 ]
Hagen, Fred [2 ]
Frontier, Alison J.
Jordan, Craig T. [1 ]
机构：
[1] Univ Rochester, Med Ctr, Wilmot Canc Ctr, Rochester, NY 14642 USA
[2] Univ Rochester, Med Ctr, Prote Core, Rochester, NY 14642 USA
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.1338.1338
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1338
引用
收藏
页数：2
相关论文
共 50 条
  • [21] CD200 expression marks leukemia stem cells in human AML
    Ho, Jenny M.
    Dobson, Stephanie M.
    Voisin, Veronique
    McLeod, Jessica
    Kennedy, James A.
    Mitchell, Amanda
    Jin, Liqing
    Eppert, Kolja
    Bader, Gary
    Minden, Mark D.
    Dick, John E.
    Wang, Jean C. Y.
    BLOOD ADVANCES, 2020, 4 (21) : 5402 - 5413
  • [22] Dasatinib Enhances Targeting of Human AML Leukemia Stem Cells by Chemotherapeutic Agents Via Activation of p53
    Dos Santos, Cedric
    McDonald, Tinisha
    Ho, YinWei
    Liu Hongjun
    Lin, Allen
    Forman, Stephen J.
    Ya-Huei, Kuo
    Bhatia, Ravi
    BLOOD, 2012, 120 (21)
  • [23] TIM-3 Is a Promising Target to Selectively Kill Acute Myeloid Leukemia Stem Cells
    Kikushige, Yoshikane
    Shima, Takahiro
    Takayanagi, Shin-ichiro
    Urata, Shingo
    Miyamoto, Toshihiro
    Iwasaki, Hiromi
    Takenaka, Katsuto
    Teshima, Takanori
    Tanaka, Toshiyuki
    Inagaki, Yoshimasa
    Akashi, Koichi
    CELL STEM CELL, 2010, 7 (06) : 708 - 717
  • [24] Acquired expression of osteopontin selectively promotes enrichment of leukemia stem cells through AKT/mTOR/PTEN/β-catenin pathways in AML cells
    Mohammadi, Saeed
    Ghaffari, Seyed H.
    Shaiegan, Mojgan
    Zarif, Mahin Nikougoftar
    Nikbakht, Mohsen
    Birgani, Shiva Akbari
    Alimoghadam, Kamran
    Ghavamzadeh, Ardeshir
    LIFE SCIENCES, 2016, 152 : 190 - 198
  • [25] RAD52-Dependent Synthetic Lethality Eradicates Leukemia Stem Cells
    Cramer, Kimberly
    Nieborowska-Skorska, Margaret
    Slupianek, Artur
    Sliwinski, Tomasz
    Irvine, David
    Copland, Mhairi
    Skorski, Tomasz
    BLOOD, 2012, 120 (21)
  • [26] Targeting NUP214 Eradicates Leukemia Stem Cells By Inducing Ferroptosis
    Chen, Zhe
    Wu, Feng
    Li, Lei
    Hou, Yu
    BLOOD, 2023, 142
  • [27] HSP90 Inhibitor 17-AAG Selectively Eradicates Lymphoma Stem Cells
    Newman, Bryan
    Liu, Yan
    Lee, Hsiu-Fang
    Sun, Duxin
    Wang, Yin
    CANCER RESEARCH, 2012, 72 (17) : 4551 - 4561
  • [28] NEW APPROACHES TO TARGET LEUKEMIA STEM CELLS
    Takenaka, Katsuto
    ANNALS OF ONCOLOGY, 2014, 25
  • [29] Identifying compounds to selectively target glioblastoma stem like cells
    Harford-Wright, E.
    Gavard, J.
    FEBS JOURNAL, 2014, 281 : 778 - 779
  • [30] Low-dose daunorubicin to target leukemia stem cells in newly diagnosed and relapsed/refractory AML
    Lin, Tara L.
    Perry, John M.
    He, Xi
    Reed, Gregory
    Zhang, Na
    Weir, Scott
    McGuirk, Joseph
    Li, Linheng
    CANCER RESEARCH, 2019, 79 (13)
12345